RxDoctor Payments Data

Kristy Lewis, NP

Family · Gravette, ARNPI 1184084097

Payments from drug & device makers

$1,008in general payments, 2019–2025

Across 64 payments — averaging $15.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$210
  • AstraZeneca$204
  • Bayer$81
  • Amgen$54
  • Novo Nordisk$52
  • Abbott$52
  • plus $353 from 12 others

What the payments were for

  • Food & beverage$1,008100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,008 in reported general payments places this provider in the 65th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$32,943
Medicare patients
163
Services billed
706

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide67$63,117
JardianceEmpagliflozin79$48,142
EliquisApixaban22$24,700
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog17$16,328
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$11,269
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog16$10,649
SynthroidLevothyroxine Sodium106$3,624
Wixela InhubFluticasone Propion/Salmeterol21$2,863
Albuterol Sulfate HfaAlbuterol Sulfate51$1,293
Atorvastatin Calcium114$1,052
Omeprazole87$915
Easy Touch Pen NeedlePen Needle, Diabetic14$679
Losartan Potassium89$675
Gabapentin56$525
Fluticasone Propionate52$522

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$52$63,11767 claims
GSKTrelegy Ellipta$42$11,26916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,103 family providers in Arkansas.

Other family in Gravette

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →